tiprankstipranks
HEROZ, Inc. (JP:4382)
:4382
Japanese Market
Want to see JP:4382 full AI Analyst Report?

HEROZ, Inc. (4382) AI Stock Analysis

1 Followers

Top Page

JP:4382

HEROZ, Inc.

(4382)

Select Model
Select Model
Select Model
Neutral 56 (OpenAI - 5.2)
Rating:56Neutral
Price Target:
¥731.00
▼(-14.70% Downside)
Action:Reiterated
Date:06/13/26
The score is primarily supported by improving fundamentals (revenue growth, return to profitability in 2026, and positive free cash flow), but is held back by historically volatile margins/cash flows and a mixed technical setup with a negative MACD and price below longer-term moving averages. Valuation is also a drag due to the negative P/E and no provided dividend yield.
Positive Factors
Revenue growth & profitability turnaround
Multi-year revenue expansion and a shift to positive net income in 2026 indicate durable demand for HEROZ's AI offerings. A sustained return to profitability improves internal funding for R&D and reduces reliance on external capital, strengthening long-term competitive positioning.
Negative Factors
Volatile margins and earnings
Large swings in margins and profitability signal execution and demand variability risk. Such volatility complicates forecasting, reduces investor and lender confidence, and means earnings could reverse quickly if revenue growth slows or cost control weakens, stressing long-term stability.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue growth & profitability turnaround
Multi-year revenue expansion and a shift to positive net income in 2026 indicate durable demand for HEROZ's AI offerings. A sustained return to profitability improves internal funding for R&D and reduces reliance on external capital, strengthening long-term competitive positioning.
Read all positive factors

HEROZ, Inc. (4382) vs. iShares MSCI Japan ETF (EWJ)

HEROZ, Inc. Business Overview & Revenue Model

Company Description
HEROZ, Inc. engages in planning, developing, and operating of intellectual games for smartphones by using its artificial intelligence and machine learning technology in Japan and internationally. The company is involved in the development of vario...
How the Company Makes Money
null...

HEROZ, Inc. Financial Statement Overview

Summary
Financials show a turnaround with strong multi-year revenue growth and a return to positive net income in 2026, supported by positive operating cash flow and free cash flow. However, profitability and cash flow have been volatile across years, and leverage is higher than 2021–2022, increasing sensitivity to any earnings downturn.
Income Statement
62
Positive
Balance Sheet
66
Positive
Cash Flow
59
Neutral
BreakdownTTMApr 2026Apr 2025Apr 2024Apr 2023Apr 2022
Income Statement
Total Revenue6.04B6.42B5.93B4.84B2.98B1.48B
Gross Profit2.71B2.92B2.69B2.39B1.35B553.36M
EBITDA629.72M970.92M566.25M-343.40M-168.66M240.52M
Net Income-143.50M376.03M-177.71M-1.13B-574.33M49.40M
Balance Sheet
Total Assets8.09B8.50B8.19B7.69B8.67B6.66B
Cash, Cash Equivalents and Short-Term Investments1.41B1.95B3.15B2.74B3.80B3.66B
Total Debt1.93B1.65B2.05B1.40B1.50B0.00
Total Liabilities2.83B2.64B2.99B2.55B2.59B219.21M
Stockholders Equity4.63B5.06B4.64B4.79B5.87B6.44B
Cash Flow
Free Cash Flow0.00511.10M132.13M316.48M460.41M194.52M
Operating Cash Flow0.00592.83M219.03M464.00M483.38M198.15M
Investing Cash Flow0.0033.93M-479.27M-1.21B-144.47M-2.09B
Financing Cash Flow0.00-405.56M664.63M-306.18M-200.78M1.00K

HEROZ, Inc. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price857.00
Price Trends
50DMA
783.82
Negative
100DMA
807.44
Negative
200DMA
891.55
Negative
Market Momentum
MACD
-10.82
Positive
RSI
39.35
Neutral
STOCH
4.20
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4382, the sentiment is Negative. The current price of 857 is above the 20-day moving average (MA) of 740.95, above the 50-day MA of 783.82, and below the 200-day MA of 891.55, indicating a bearish trend. The MACD of -10.82 indicates Positive momentum. The RSI at 39.35 is Neutral, neither overbought nor oversold. The STOCH value of 4.20 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4382.

HEROZ, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
¥11.80B43.8912.23%38.11%
65
Neutral
¥12.55B82.0126.18%-33.28%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
60
Neutral
¥19.55B24.370.82%6.86%37.74%
56
Neutral
¥10.84B28.708.35%
56
Neutral
¥3.83B17.5121.37%30.42%
46
Neutral
¥22.43B-116.00131.28%76.67%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4382
HEROZ, Inc.
710.00
-536.00
-43.02%
JP:3853
Asteria Corporation
1,173.00
494.91
72.98%
JP:4425
Kudan, Inc.
1,893.00
803.00
73.67%
JP:4476
AI CROSS Inc
956.00
-884.00
-48.04%
JP:5572
Ridge-i Inc.
2,641.00
-346.00
-11.58%
JP:5586
Laboro.AI, Inc.
793.00
-403.00
-33.70%

HEROZ, Inc. Corporate Events

HEROZ Publishes Excerpt of FY04/2026 Full-Year Financial Results
Jun 15, 2026
HEROZ, Inc. released an English excerpt of its FY04/2026 full-year financial results on June 12, 2026, signaling it is sharing key performance information with a broader, potentially international, investor audience. While the document provided is...
HEROZ Returns to Profit and Strengthens Balance Sheet as It Forecasts Further Growth
Jun 12, 2026
HEROZ, Inc. reported consolidated net sales of ¥6.42 billion for the fiscal year ended April 30, 2026, an 8.3% increase, with operating profit surging 70.7% to ¥523 million and profit attributable to owners of the parent rebounding to &#...
HEROZ Lifts Full-Year Profit Outlook on Subsidiary Sale and Tax Gains
Jun 9, 2026
HEROZ, Inc. revised its full-year consolidated earnings forecast for the fiscal year ending April 30, 2026, modestly raising projections for net sales, EBITDA and operating income while sharply increasing expected net income. The company now antic...
HEROZ to Sell SaaS Integration Subsidiary StrategIT to GMO GlobalSign Holdings
Apr 20, 2026
HEROZ, Inc. has agreed to transfer 79,499 shares of its consolidated subsidiary StrategIT Co., Ltd. to GMO GlobalSign Holdings K.K., with completion targeted around April 30, 2026. StrategIT develops and operates the iPaaS-based SaaS integration s...
HEROZ Acquires Majority Stake in AKM Consulting to Drive AI BPaaS Expansion
Apr 20, 2026
HEROZ, Inc. has moved to make AKM Consulting Co., Ltd., which operates the BAKUNAGE brand, a subsidiary by acquiring a 70% equity stake, advancing its HEROZ 3.0 strategy focused on AI BPaaS in back-office operations. AKM Consulting offers a broad ...
HEROZ to Acquire AKM Consulting to Advance AI-Driven Back-Office BPaaS
Apr 20, 2026
HEROZ, Inc. has resolved to acquire all shares of AKM Consulting Co., Ltd., a fast-growing back-office BPO and management consulting provider for startups, and make it a specified subsidiary. By integrating AKM Consulting’s expertise in acco...
HEROZ Moves to Fully Integrate Vario Secure to Unlock AI Synergies and Boost EPS
Apr 14, 2026
HEROZ, Inc. plans to fully integrate Vario Secure, Inc., eliminating their parent-subsidiary dual listing structure that has impeded effective collaboration since a 2022 capital alliance. By making Vario Secure a wholly owned subsidiary, HEROZ aim...
HEROZ to Acquire Variosecure in Share Exchange Management Integration
Apr 14, 2026
HEROZ, Inc. and Variosecure, Inc. have agreed to a management integration through a share exchange that will make HEROZ the wholly owning parent and Variosecure its wholly owned subsidiary. The deal, approved by both boards, is structured so HEROZ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 13, 2026